UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2022

 

HAPPINESS DEVELOPMENT GROUP LIMITED

(Exact name of registrant as specified in its charter)

 

No. 11, Dongjiao East Road, Shuangxi, Shunchang, Nanping City

Fujian Province, People’s Republic of China
+86-0599-782-8808

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒         Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

 

 

 

 

 

Explanatory Note

 

On March 4, 2022, Fujian Happiness Biotech Co., Limited, (“Happiness Fujian”) a limited liability company organized under the laws of the PRC and a wholly-owned indirect subsidiary of Happiness Development Group Limited (the “Company”), entered into a certain equity transfer agreement (the “Agreement”) with the equity owners (the “Sellers”) of Fuzhou Hekangyuan Trading Co., Ltd. (“Hekangyuan”) for the purchase of 100% of the equity interest of Hekangyuan (the “Equity Interests”). The parties agreed that the valuation of all the equity interests of Hekangyuan is $12 million. The total consideration to be paid for the Equity Interests are $8 million in cash and 10 million Class A ordinary shares of the Company (the “Shares”) to be issued to the Sellers or their respective appointees. The Company will issue the Shares in reliance on the exemptions from registration provided by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder. The closing of the transaction shall take place after all necessary consents and regulatory approvals have been obtained. 

 

Hekangyuan is a private company incorporated in the PRC with its principal business engaged in distribution of healthcare products in Fuzhou, China. Upon the completion of the proposed acquisition, Hekangyuan will become a wholly owned subsidiary of Happiness Fujian and an indirect subsidiary of the Company.

 

According to the Agreement, in the event that the aggregate net profits of Hekangyuan in the next three fiscal years are less than $4.5 million, than the Company has the right to request the Sellers to purchase back the Equity Interests at the price $12 million in cash.

 

The description of the Agreement contained in this Report on Form 6-K does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement which is filed herewith as Exhibit 4.1, and incorporated herein by reference.

 

The audited financial statements of Hekangyuan and the unaudited pro forma financial information of the Company after giving effect to the consummation of the acquisition of Hekangyuan are also filed herewith as Exhibits 99.1 and 99.2.

 

Exhibits

 

Exhibit No.   Description
4.1   Equity Transfer Agreement, dated March 4, 2022, by and between the Sellers, Happiness Fujian, Hekangyuan and the Company
23.1   Consent of Beijing Huahao Certified Public Accountants General Partnership
99.1   Fuzhou Hekangyuan Trading Co., Ltd.’s audited Financial Statements
99.2   Happiness Development Group Limited Unaudited Pro Forma Condensed Consolidated Financial Statements

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

  Happiness Development Group Limited
     
Date: March 7, 2022 By: /s/ Xuezhu Wang
   

Xuezhu Wang

Chief Executive Officer

 

 

2

 

Exhibit 4.1

 

 

 

EQUITY TRANSFER CONTRACT

 

WITH

 

CUNHUI LIN, YANQING LIU

 

CONCERNING

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

 

 

TABLE OF CONTENT
     
CHAPTER 01 DEFINITION AND INTERPRETATION   1
     
Article 01 Definition   1
     
CHAPTER 02 EQUITY TRANSFER   2
     
Article 02 Transfer of Equity   2
Article 03 Equity Transfer Price and Trading Condition   2
Article 04 Tax Payable Under Equity Transfer   3
     
CHAPTER 03 REPRESENTATIONS AND WARRANTIES OF THE PARTIES   4
     
Article 05 Representations and Warranties of the Parties   4
     
CHAPTER 04 DISCLOSURE, REPRESENTATION AND WARRANTIES OF THE SELLER   4
     
Article 06 Disclosure, Representation and Warranties of the Seller   4
Article 07 General Representations and Warranties of the Seller   5
Article 08 Ownership   7
Article 09 Special Statements and Guarantees of the Seller   8
     
CHAPTER 05 DISCLOSURE, STATEMENTS AND WARRANTIES OF THE BUYER   10
     
Article 10 Disclosures, Statements and Warranties of the Buyer   10
     
CHAPTER 06 CONFIDENTIALITY   10
     
Article 11 Confidentiality   10
     
CHAPTER 07 BREACH OF CONTRACT   11
     
Article 12 Liabilities for Violation of Statement or Warranties   11
Article 13 Lliabilities for Breach of Contract   12
     
CHAPTER 08 FORCE MAJEURE   12
     
Article 14 Force Majeure   12
     
CHAPTER 09 SETTLEMENT OF DISPUTES   13
     
Article 15 Arbitration   13
Article 16 Validity of Arbitral Award   13
Article 17 Continuation of Rights and Obligations   13
     
CHAPTER 10 APPLICABLE LAW   13
     
Article 18 Applicable Law   13
     
CHAPTER 11 OTHERS   14
     
Article 19 Waiver   14
Article 20 Transfer   14
Article 21 Modification   14
Article 22 Separability   14
Article 23 Validity of the Contents and Annexes   14
Article 24 Notices   15
Article 25 Entire Agreement   16

 

i

 

EQUITY TRANSFER CONTRACT

 

This equity transfer contract (hereinafter referred to as the “contract”) is signed by the following parties in Fuzhou, China on March 4, 2022.

 

Party A, Happiness Development Group Limited (Nasdaq: HAPP), and its subsidiary Fujian Happiness Biotech Co., Limited (hereinafter referred to as the “Buyer”), whose address is 11 Dongjiao East Road, Shuangxi Town, Shunchang County, Nanping City;

 

Party B:

Cunhui Lin, ID No.: 350121198502190726

Yanqing Liu, ID No.: 360781199906255122

 

Party C, Fuzhou Hekangyuan Trading Co., Ltd., with registered office at 1103 IFC, No.1 Wanglong 2nd Rd.,Taijiang District, Fuzhou City, Fujian Province,

 

The above Party B is referred to as the “Seller”, and the Seller and the Buyer are collectively referred to as the “parties” and individually referred to as the “party” in the following.

 

Given:

 

(1)Party B owns 100% of the equity of Fuzhou Hekangyuan Trading Co., Ltd. (hereinafter referred to as “Hekangyuan”), and Party B can fully exercise all its rights as a shareholder;

 

(2)Party B is willing to transfer to the Buyer all of Hekangyuan’s equity (hereinafter referred to as “equity transfer”) held by it in accordance with the conditions and terms stipulated in this contract;

 

(3)The Buyer is willing to retain all of the equity of Hekangyuan held by the Seller in accordance with the conditions and terms stipulated in this contract.

 

Therefore, based on the principle of equality and mutual benefit, the parties to this contract have negotiated amicably and agreed to reach the following agreements in accordance with the “Company Law of the People’s Republic of China”, “Interim Provisions on Domestic Investment of Foreign-Invested Enterprises” and other relevant Chinese laws and regulations.

 

 

 

CHAPTER 01 Definition and Interpretation

 

Article 01 Definition

 

Unless otherwise indicated or the context requires otherwise, references in this contract to:

 

Hekangyuan” refers to Fuzhou Hekangyuan Trading Co., Ltd., a limited liability company incorporated under the laws of China, with a registered capital of RMB 10 million, registration number 350105100188299, and registered address at 1103 IFC, No.1 Wanglong 2nd Rd.,Taijiang District, Fuzhou City, Fujian Province.

 

China” or the “PRC” refers to the People’s Republic of China, excluding, for the purposes of this contract only, Hong Kong, Macau and Taiwan.

 

Claim” refers to all claims, actions, judgment liability, damage compensation, fees and expenses (including attorney’s fees, litigation fees and expenses).

 

Signing Date” refers to the date of signing of this contract.

 

Hinder” refers to mortgage, transfer, lien, charge, pledge, retention of title, right to purchase, security interest, option, right of first refusal and other restrictions and conditions, including:

 

(a)Any right or power granted or reserved in relation to or affecting the transfer of equity; or

 

(b)The rights or powers arising from the transfer of equity in a trust transfer, lien, pledge, power of attorney or other form; or

 

(c)Guarantee the repayment of a debt or any other pecuniary obligation or the performance of any other obligation in the form of a guarantee.

 

1

 

 

Substantial adverse changes” refers to (1) Hekangyuan is investigated (the investigation may subject Hekangyuan to administrative penalties) or punished by the government; (2) Hekangyuan is involved in any litigation, arbitration or any other judicial proceedings; (3) any changes that has or is reasonably believed to have a substantial adverse impact on Hekangyuan’s finance, business, assets, liabilities, operating results or Hekangyuan’s future prospects.

 

RMB” refers to the legal currency of China.

 

Third party” refers to any natural person, legal person, other organization or entity other than the parties to the contract.

 

Working day” refers to the day when banks are open for business.

 

CHAPTER 02 Equity Transfer

 

Article 02 Transfer of Equity

 

According to the conditions agreed in this contract, the Seller agrees to transfer to the Buyer, and the Buyer agrees to retain from the Seller 100% of Hekangyuan’s equity and all rights and obligations under the transfer of the equity, including but not limited Hekangyuan or the right to issue shares (if any), without any claims or hindrances.

 

Article 03 Equity Transfer Price and Trading Condition

 

After negotiation between the Seller and the Buyer, it is finally confirmed that the Hekangyuan transaction is valued at USD 12 million. The Buyer should pay USD 8 million (or equivalent in RMB) in cash and the remaining part would be paid with the restricted shares of Party A’s NASDAQ-listed company HAPP (hereinafter referred to as the “HAPP stock consideration”). The shares will be issued to the Seller and/or its designated person, that is, the “Recipient” (a single party is referred to as “each Recipient”). The stock price is calculated at US$0.40 per share. A total of 10 million shares will be issued and the specific number of shares issued to each Recipient shall be designated by the Seller.

 

2

 

 

The Buyer will pay the HAPP stock consideration to the Seller within ten working days after the signing of the equity transfer contract. Both parties agreed to the following goals of Hekangyuan’s net income and net profit as follows:

 

1: Hekangyuan’s annual financial report for the 2022 fiscal year is audited and in compliance with US GAAP, with a net sales income of no less than 23 million USD (“Expected Net Sales Revenue for the 2022 Fiscal Year”), and a net profit of no less than 1.2 million USD (“Expected Net Profit for the 2022 Fiscal Year”).

 

2: Hekangyuan’s annual financial report for the 2023 fiscal year is audited and in compliance with US GAAP, with a net sales income of no less than 30 million USD (“Expected Net Sales Income for the 2023 fiscal year”), and a net profit of no less than 1.6 million USD (“Expected Net Profit for the 2023 Fiscal Year”).

 

3: Hekangyuan’s annual financial report for the 2024 fiscal year is audited and in compliance with US GAAP, with a net sales income of no less than 36 million USD (“Expected Net Sales Income for the 2024 fiscal year”), and a net profit of no less than 2 million USD (“Expected Net Profit for the 2024 Fiscal Year”).

 

The parties further agree that if the total net profit of Hekangyuan in the next three fiscal years is less than 4.5 million USD, the Buyer has the right to request the Seller to repurchase all the equity interests of Hekangyuan that was acquired by the Buyer for an aggregate price of 12 million USD in cash.

 

Article 04 Tax Payable Under Equity Transfer

 

Any taxes and fees arising from the performance of the terms of this contract shall be borne by the relevant taxpayers and payers in accordance with the relevant laws and regulations of China.

 

3

 

 

CHAPTER 03 Representations and Warranties of the Parties

 

Article 05 Representations and Warranties of the Parties

 

5.1The Seller and the Buyer hereby confirm that this contract shall become a legally binding document on all parties from the date of signing.

 

5.2When signing this contract, the Seller and the Buyer declare that the documents provided to the other party or its advisory consultant (including but not limited to lawyers, appraisers, financial consultants, etc.) before the signing date of this contract are still valid In case of any inconsistency with this contract, this contract shall prevail.

 

5.3The Seller and the Buyer agree that any contracts or documents related to equity transfer signed before this contract will automatically become invalid after this contract takes effect.

 

5.4All parties to this contract will make joint efforts and cooperate with each other to complete all procedures related to this equity transfer, including but not limited to registration, filing, etc. The expenses incurred shall be borne by Hekangyuan.

 

CHAPTER 04 Disclosure, Representation and Warranties of the Seller

 

Article 06 Disclosure, Representation and Warranties of the Seller

 

The Seller hereby represents and warrants to the Buyer:

 

6.1All materials and facts related to Hekangyuan held or known by the Seller that have a substantial and adverse impact on the Seller’s ability to fully perform its obligations under this contract, or if disclosed to the Buyer, would make a material impact on the Buyer’s willingness to sign and perform its obligations under the contract, have been disclosed to the Buyer. Moreover, the information provided by the Seller to the Buyer does not contain any falseor misleading statement.

 

4

 

 

6.2There is no lawsuit, arbitration or other legal or administrative procedures or government investigation brought against the Seller, which is ongoing and will seriously affect its signing of this contract or performance of its obligations under this contract.

 

6.3With regard to the documents and information provided by the Seller to the Buyer and or its advisory consultant (including but not limited to lawyers, appraisers, financial consultants, etc.) before the signing date, the Seller hereby jointly undertakes:

 

6.3.1 Copies of all originals are true and complete and such originals are true and complete

 

6.3.2 All originals provided to the Seller and/or its advisory consultant are true and complete

 

6.3.3 The signatures (seals) on all originals or copies provided to the Seller and or its advisory consultant are true; and

 

6.3.4 The Seller has drawn the attention of the Buyer and/or its advisory consultant to all major matters concerning the transaction under this contract.

 

Article 07 General Representations and Warranties of the Seller

 

7.1Party B has the full authority to sign this contract and perform all its obligations under this contract. Party B’s signing of this contract and performance of its obligations under this contract will not conflict with any laws, regulations, provisions, authorization or approval of any government agency or department, or any contract or agreement which Party B is a party to or is bound by, nor will lead to violation of the above provisions, or constitute non performance or failure to perform the above provisions.

 

5

 

 

7.2Each Recipient hereby makes the following representations, warranties and commitments:

 

(a) Rights. The Recipient has the full authority to sign and perform the transaction and any terms of this agreement. This agreement has been duly signed and delivered to the Recipient. The terms of this agreement are legally binding on the Recipient, except in the following circumstances: 1) Subject to bankruptcy, liquidation, reorganization, freezing and other laws that generally affect the implementation of creditors’ rights; 2) Subject to the law of equity limitations on remedies.

 

(b) Experience. The Recipient has certain experience and knowledge in the economic and commercial fields, and can evaluate the value and risk of the investment. The Recipient promises that they will take economic risks for their investment behavior. The Recipient believes that they have obtained all the information they deem necessary to decide whether to buy the stock. The Recipient further stated that the Recipient had the opportunity to ask HAPP about the terms of the HAPP stock issuance and HAPP’s business, assets, and financial conditions, and received a reply to the above questions from HAPP.

 

(c) Purchase entirely for one’s own benefit. The Recipient acknowledged that the company relies on the Recipient’s representations to the company to reach an agreement with the Recipient. By signing this agreement, the Recipient hereby confirms that the Recipient purchased the shares solely for the benefit of their own investment, not as the nominee holder or agent of others. There is no purpose of resale or distribution of any part of the shares, and there is also no intention to sell or distribute or share any part of the shares with others at present. By signing this agreement, the Recipient further states that the Recipient has not entered into any contract with any individual for the purchase, sale, transfer and sharing of any shares.

 

(d) Accredited investors. The Recipient is an “accredited investor” as defined in Rule 501 (a) of Regulation D of the Securities Act of 1933.

 

(e) Restricted securities. The Recipient understands that the securities it purchases are “restricted securities” as defined by the U.S Securities Act because the securities are not obtained through HAPP public offering. The Recipient understands that under this act and corresponding regulations, if the restricted securities are unregistered, it can only be resold under certain conditions. According to the U.S. Securities Act, the shares must be held indefinitely before they are effectively registered or exempted from registration requirements. In this regard, the Recipient undertakes that it is familiar with Rule 144 of the U.S. Securities Act and understands its restrictions on resale.

 

6

 

 

(f) Legend. The restrictive legend on the stock certificate can be removed only when: a) Sold in accordance with the provisions of the Rule 144 of the U.S. Securities Act (or its subsequent relevant provisions) or through effective registration; or b) the lawyer issues an opinion and reasonably believes that the restrictive legend on the stock certificate can be removed.

 

“These securities were not registered in accordance with the Securities Act of 1933 Amendment. They cannot be sold, publicly sold, pledged, mortgaged, or transferred in any other way, except in the following conditions: a) Exemption from registration under Rule 144 (if applicable); b) In accordance with all applicable securities acts and regulations in the United States”.

 

The Recipient also understands that such stock certificates may be subject to any state securities regulations or other government departments’ restrictions on the issuance of securities.

 

Article 08 Ownership

 

8.1The Seller is the legal owner of the transferred equity and has all the authorization and rights to transfer the equity to the Buyer.

 

8.2The Seller promises and guarantees that as of the payment date, there is no claim or hindrance in any form (including but not limited to any form of option, acquisition right, mortgage, pledge, guarantee, lien or other forms of third-party interests) under the transferred equity.

 

8.3There is no lawsuit, arbitration or other legal or administrative procedure or government investigation against the Seller, that is ongoing and will seriously affect the signing or performance of the obligations of this contract.

 

7

 

 

Article 09 Special Statements and Guarantees of the Seller and Hekangyuan

 

The Seller and Hekangyuan hereby separately and jointly claims and guarantees to the Buyer that:

 

9.1Hekangyuan is a duly organized and reputable enterprise under the Chinese laws and regulations.

 

9.2Hekangyuan legally and effectively owns all the land, plant, machinery and equipment and other assets it occupies. For any land and real estate with defective rights, Hekangyuan promise to take all measures to ensure that Hekangyuan can legally own the use right of all land and the ownership of all real estate. Hekangyuan’s commitment is not limited by time and will continue to be effective after the delivery of this contract. If Hekangyuan or the Buyer suffers any loss or is punished by any government department due to any of the above problems after the equity transfer, the Seller shall bear joint and several liabilities and shall compensate the Buyer in full.

 

9.3Hekangyuan has never been and is not subject to any other investigation, litigation, dispute, claim or other procedures (whether existing, pending or threatened), nor has it been punished. The Seller and Hekangyuan also foresee that any administrative agency in China will not impose any punishment on Hekangyuan due to the problems existing in Hekangyuan before the equity transfer, except that Hekangyuan has disclosed to the Buyer before the delivery. Before signing this contract, the Seller and Hekangyuan has fully disclosed all the information of Hekangyuan to the Buyer.

 

9.4Hekangyuan has obtained all necessary approvals, permits, consents, has completed the necessary registration and filing for production and operation, and has conducted business operations and entered into legally binding contracts and documents in accordance with the business scope of its business license. If the Buyer and/or Hekangyuan suffer any punishment, damage, loss, etc. due to the lack of any business approval, license, consent and registration before the equity transfer, the Seller shall bear joint and several liabilities and shall then compensate the Buyer in full.

 

8

 

 

9.5The production, operation and business of Hekangyuan fully comply with all relevant laws and regulations of China. If Hekangyuan suffers any damage or loss due to any administrative punishment for any matter before the signing of this contract, the Seller shall fully compensate the Buyer and Hekangyuan for all damage and loss so that the Buyer and Hekangyuan will not suffer any damage.

 

9.6All liabilities of Hekangyuan have been disclosed as of the signing date of this contract. The Seller shall be jointly and severally liable to the Buyer and Hekangyuan for undisclosed liabilities and unpaid interest due and payable, so that the Buyer will not be damaged.

 

9.7From the signing date of this contract to the payment date, all financial expenses of Hekangyuan can only be carried out with the joint signature and consent of the financial personnel dispatched by the Buyer and the financial personnel of the Seller and Hekangyuan.

 

9.8Hekangyuan has not provided guarantee (including but not limited to mortgages, pledges, guarantees, etc.) for any other company, enterprise, economic entity or any natural person. If Hekangyuan suffers any damage or loss due to such undisclosed guarantee, the Seller shall bear joint and several liabilities and shall compensate the Buyer in full.

 

9.9Before signing this contract, the Seller and HEkangyuan have fully disclosed all information of all debts undertaken by Hekangyuan. As of the closing date, such information is still complete, reliable, accurate and true.

 

9.10The production process and technology adopted by Hekangyuan as of the delivery date and the intellectual property rights owned by Hekangyuan, including but not limited to trademarks and proprietary technologies, fully comply with relevant Chinese laws, regulations, standards and specifications, and that there is no illegal act of infringing other people’s patents, proprietary technologies and other intellectual property rights. If Hekangyuan suffers any punishment, damage or loss due to such illegal acts, the Seller shall be jointly and severally liable and shall compensate the Buyer in full.

 

9.11If the Seller and Hekangyuan violate any of the above statements and guarantees, or if the Seller fails to complete all preconditions specified in Annex I of this contract, the Buyer has the right to require the Seller to bear joint and several liabilities and compensate the Buyer for direct and indirect losses, so as to protect the Buyer from any losses.

 

9

 

 

CHAPTER 05 Disclosure, Statements and Warranties of the Buyer

 

Article 10 Disclosures, Statements and Warranties of the Buyer

 

The Buyer hereby claims and guarantees to the Seller that:

 

10.1The Fujian Happiness Biotech Co., Limited is an enterprise duly organized and in good standing under the laws of China.

 

10.2The signing of this contract and the performance of its obligations under this contract by the transferee will not conflict with the articles of association or internal rules of the transferee, any laws, regulations, provisions, authorization or approval of any government agency, provisions of any contract or agreement to which the transferee is a party or is bound.

 

10.3The Buyer has no ongoing litigation, arbitration, other legal or administrative procedures or government investigations that seriously affect its ability to sign the contract or perform its obligations under the contract.

 

CHAPTER 06 Confidentiality

 

Article 11 Confidentiality

 

11.1For the confidential and proprietary information that one party has disclosed or may disclose to the other party about their respective business or financial status and other confidential matters, unless otherwise specified in other confidentiality agreements, all parties in the contract who accept all the above confidential information agree that:

 

11.1.1Confidential information shall be kept confidential;

 

11.1.2Except for the employees of one party under the contract who need to know the above confidential information to perform their duties, neither party shall disclose the information to any third party or entity.

 

10

 

 

11.2The provisions of article 11.1 above shall not apply to the following confidential information where:

 

11.2.1Before the disclosing party discloses to the receiving party, the receiving party has been able to obtain the information from the written records and the written records can prove that it is known to the receiving party;

 

11.2.2Materials are not publicly known due to the recipient’s breach of the contract;

 

11.2.3Information obtained by the receiving party from a third party does not undertake any confidentiality obligation for confidential information.

 

CHAPTER 07 Breach of Contract

 

Article 12 Liabilities for Violation of Statement or Warranties

 

12.1If any error or omission is found in the statement or guarantee of either party to the contract, which has or may have a significant or material impact on the signing of the contract by either party, or any statement or guarantee is found to be misleading or untrue in any way, the other party has the right to claim from the defaulting party for the error or omission and to make full compensation for any loss, damage, cost or expense (including attorney’s fees and litigation and arbitration fees) caused by misleading, untrue statements or warranties.

 

11

 

 

12.2The interpretation of each statement and warranty listed in the contract shall be independent.

 

12.3For the avoidance of doubt, the Seller hereby unconditionally and irrevocably agrees and confirms that it will be liable for any breach of its representations or warranties.

 

Article 13 Liabilities for Breach of Contract

 

13.1In case of any breach of contract by one party, the breaching party shall bear the liability for breach of contract to the other party in accordance with the provisions of the contract and Chinese laws and regulations. If both parties breach the contract, one party shall bear the loss or damage or any other liability caused by their breach to the other party.

 

CHAPTER 08 Force Majeure

 

Article 14 Force Majeure

 

14.1“Force majeure” refers to special events such as earthquake, typhoon, flood, fire, war and political unrest, and other events considered as “force majeure” in relevant Chinese laws and regulations.

 

14.2If a force majeure event occurs, the obligations of the party affected by the event will be suspended during the event and related terms will be automatically extended. The extended period is the same as the suspension period, and the party will not bear the liability for breach of contract listed in the contract.

 

14.3The party claiming force majeure shall immediately notify the other parties in writing and provide sufficient evidence of the occurrence and existence of the force majeure issued by the notary office within seven (7) days thereafter. The party claiming force majeure shall use its best efforts to eliminate the adverse effects of force majeure

 

12

 

 

CHAPTER 09 Settlement of Disputes

 

Article 15 Arbitration

 

15.1Any disputes arising from this contract between the parties shall first be settled through friendly negotiation. If a dispute cannot be settled in this way within sixty (60) days after the commencement of friendly negotiation, either party may submit the dispute to China International Economic and Trade Arbitration Commission in Beijing for arbitration in accordance with its arbitration rules in force at that time.

 

Article 16 Validity of Arbitral Award

 

The arbitration award is final and shall be binding on all parties under this contract. The parties agree to be bound by and act in accordance with the award.

 

Article 17 Continuation of Rights and Obligations

 

During the arbitration after the dispute occurs, each party shall continue to exercise its other rights and perform its other obligations under the contract except for the matters in dispute.

 

CHAPTER 10 Applicable Law

 

Article 18 Applicable Law

 

The formation, validity, interpretation and execution of this contract shall be governed and bound by the laws of the People’s Republic of China. All disputes arising under this contract shall be decided in accordance with the Chinese law. If there is no provision in Chinese law on any issue related to this contract, reference shall be made to the general international business practices.

 

13

 

 

CHAPTER 11 Others

 

Article 19 Waiver

 

The failure or delay of either party to exercise a right under the contract shall not be regarded as a waiver of such right; Any single or partial exercise of a right does not exclude the re-exercise of the right in the future.

 

Article 20 Transfer

 

Unless otherwise specified in the contract, without the prior written consent of the other parties, either party shall not transfer any of its rights and obligations under the contract in whole or in part.

 

Article 21 Modification

 

21.1This contract is signed for the benefit of all parties to this contract and their respective legal successors and assigns, on whom this contract is legally binding.

 

21.2This contract shall not be orally modified. The modification of this contract shall take effect only after the parties under this contract sign a written document with their consent.

 

Article 22 Separability

 

The invalidity of any provision of this contract shall not affect the validity of any other provision of this contract.

 

Article 23 Validity of the Contents and Annexes

 

23.1This contract shall come into force on the day when both parties sign. The signed original Chinese contract shall be made in six (6) copies. Each party shall hold one (1) original and send one (1) original copy to the competent administrative department for Industry and commerce. The remaining shall be held by Hekangyuan and the Buyer.

 

23.2The annexes to this contract are an integral part of the contract and have the same effect as the contract.

 

14

 

 

Article 24 Notices

 

24.1Unless otherwise specified in the contract, any notice or written communication sent by one party to the other party under the contract shall be written in Chinese, sent in the form of letter, express service or fax. Notices or communications delivered by courier service shall be confirmed 7 working days after delivery to the courier service company. The effective date of the notice or written communication issued in accordance with the provisions of the contract shall be the date of receipt. If it is sent by fax, the 3rd working day after sending shall be regarded as the receiving date, but it shall be proved by the fax confirmation report.

 

24.2All notices and communications shall be sent to the following addresses until one address is updated by sending a written notice to the other party by the changing party:

 

Party A’s mailing address: 

Telephone: 

Fax number: 

Recipient:

 

Party B’s mailing address: 

Telephone: 

Fax number: 

Recipient:

 

Party C’s mailing address: 

Telephone: 

Fax number: 

Recipient:

 

15

 

 

Article 25 Entire Agreement

 

This contract contributes to the entire agreement on the transactions agreed in this contract between the parties and shall replace all previous discussions, negotiations and agreements between the parties on the transactions under this contract.

 

No Content Below

 

16

 

 

In witness whereof, the duly authorized representative of Party A and Party B sign this contract on the date stated at the beginning of the document.

 

Party A: Happiness Development Group Limited and

Fujian Happiness Biotech Co., Limited

 

 

Seal and Authorized Signature: /s/ Xuezhu Wang_

 

Party B:Cunhui Lin, Yanqing Liu

 

Seal and Authorized Signature: /s/ Cunhui Lin

Seal and Authorized Signature: /s/ Yanqing Liu

 

Party C: Fuzhou Hekangyuan Trading Co., Ltd.

 

Seal and Authorized Signature: /s/ Cunhui Lin 

 

 

 

 

Exhibit 23.1

 

BEIJING HUAHAO CERTIFIED PUBLIC ACCOUNTANTS

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (file No. 333-253602) and Form F-3 (File No. 333-250026) of our report dated March 2, 2022, relating to the consolidated financial statements of Fuzhou Hekangyuan Trading Co., Ltd. for the year ended December 31, 2021 and 2020 appearing in this Form 6-K of Happiness Development Group Limited filed on March 7, 2022.

 

/s/ Beijing Huahao Certified Public Accountants General Partnership

 

Beijing, China

March 7, 2022

Exhibit 99.1

  

 

 

 

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED

DECEMBER 31, 2021 AND 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

INDEX TO FINANCIAL STATEMENTS

 

  Page
INDEPENDENT AUDITORS’ REPORT 2
   
Balance Sheets as of December 31, 2021 and 2020 3
   
Statements of Operation and Comprehensive income for the years ended December 31, 2021 and 2020 4
   
Statements of Shareholders’ Equity for the years ended December 31, 2021 and 2020 5
   
Statements of Cash Flows for the years ended December 31, 2021 and 2020 6
   
Notes to the Financial Statements 7 – 13

 

1

 

 

INDEPENDENT AUDITORS’ REPORT

 

To the Board of Directors and

Fuzhou Hekangyuan Trading Co., Ltd.

 

We have audited the accompanying financial statements of Fuzhou Hekangyuan Trading Co., Ltd. (the “Company”), which comprise the balance sheets as of December 31, 2021 and 2020, and the related statements of operations and comprehensive income, changes in shareholders’ equity, and cash flows for the years then ended, and related notes to the financial statements.

 

Management's Responsibility for the Financial Statements

 

Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

 

Auditor's Responsibility

 

Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free from material misstatement.

 

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on our judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, we consider internal control relevant to the Company's preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

 

Opinion

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial positions of Fuzhou Hekangyuan Trading Co., Ltd. as of December 31, 2021 and 2020, and the result of its operations and comprehensive income and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

/s/ Beijing Huahao Certified Public Accountants General Partnership

 

Beijing, China

March 2, 2022

 

2

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

BALANCE SHEETS

AS OF DECEMBER 31, 2021 and 2020

 

   2021   2020 
         
ASSETS        
Current assets        
Cash and cash equivalents  $139   $949,873 
Accounts receivable   680,929    2,341,933 
Inventories   1,452,354    2,389,047 
Prepayments and other current assets   5,702    199,218 
Total current assets   2,139,124    5,880,071 
Non-current assets          
Property, plant and equipment, net   308    938 
Intangible assets, net   -    661 
Total non-current assets   308    1,599 
TOTAL ASSETS  $2,139,432   $5,881,670 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities          
Accounts payable  $608,034   $5,154,693 
Taxes payable   -    20,228 
Other payables and accrued liabilities   14,786    12,123 
TOTAL LIABILITIES   622,820    5,187,044 
           
SHAREHOLDERS’ EQUITY          
Paid-in capital   69,320    69,320 
Statutory reserve   143,229    61,223 
Retained earnings   1,245,216    530,451 
Accumulated other comprehensive income   58,847    33,632 
TOTAL SHAREHOLDERS’ EQUITY   1,516,612    694,626 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $2,139,432   $5,881,670 

 

The accompanying notes are an integral part of these financial statements

 

3

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

FOR THE YEARS ENDED DECEMBER 31, 2021 and 2020

 

   2021   2020 
         
Revenues  $17,630,349   $13,517,599 
Cost of revenues   16,479,313    12,660,090 
Gross profit   1,151,036    857,509 
           
Operating expenses          
Sales and marketing expenses   1,041    690 
General and administrative   88,293    86,028 
Total operating expenses   89,334    86,718 
Income from operations   1,061,702    770,791 
           
Other income (expense)          
Interest income   1,580    2,044 
Other income (expense)   (234)   23 
Total other income   1,346    2,067 
Income before income taxes   1,063,048    772,858 
Income tax expense   (266,277)   (193,413)
Net income   796,771    579,445 
Other comprehensive income          
Foreign currency translation   25,215    33,632 
Total comprehensive income  $821,986   $613,077 

 

The accompanying notes are an integral part of these financial statements

 

4

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

STATEMENTS OF SHAREHOLDERS’ EQUITY

FOR THE YEARS ENDED DECEMBER 31, 2021 and 2020

 

 

   Paid-in
Capital
   Statutory
surplus
reserve
   Retained
earnings
   Accumulated
other
comprehensive
income
   Total
equity
 
Balance at December 31, 2019  $69,320   $-   $12,229   $-   $81,549 
Net income for the year   -    -    579,445    -    579,445 
Appropriation for surplus reserve   -    61,223    (61,223)   -    - 
Foreign currency translation adjustments   -    -    -    33,632    33,632 
Balance at December 31, 2020  $69,320   $61,223   $530,451   $33,632   $694,626 
Net income for the year   -         796,771    -    796,771 
Appropriation for surplus reserve        82,006    (82,006)   -    - 
Foreign currency translation adjustments   -    -    -    25,215    25,215 
Balance at December 31, 2021  $69,320   $143,229   $1,245,216   $58,847   $1,516,612 

 

The accompanying notes are an integral part of these financial statements

 

5

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2021 and 2020

 

   2021   2020 
         
Cash generated from operating activities        
Net income  $796,771   $579,445 
Depreciation and amortization   685    555 
Changes in          
Accounts receivable   1,696,728    (2,144,811)
Prepayments and other current assets   195,975    (175,529)
Inventories   981,561    (2,252,754)
Accounts payable   (4,615,382)   4,875,525 
Taxes payable   2,353    (20,241)
Other payables and accrued liabilities   (20,471)   19,145 
Net cash (provided by)/ used in operating activities   (961,780)   881,335 
           
Investing Activities          
Sales of assets   669    - 
Net cash provided by investing activities   669    - 
           
Effect of foreign exchange rate changes on cash   11,377    51,078 
           
Net (decrease) / increase in cash   (949,734)   932,413 
Cash and cash equivalents at the beginning of year   949,873    17,460 
Cash and cash equivalents at the end of year  $139   $949,873 
           
Cash paid for income tax  $286,748   $174,268 
Cash paid for interest expense  $-   $- 

 

The accompanying notes are an integral part of these financial statements

 

6

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

NOTES TO THE FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

1.ORGANIZATION AND NATURE OF OPERATIONS

 

The accompanying financial statements include the financial statements of Fuzhou Hekangyuan Trading Co., Ltd. (the “Company”).

 

The Company was incorporated under the law of the People’s Republic of China (“PRC”) on October 13, 2017. As of December 31, 2021, the Company was owned by Ms. Cunhui Lin and Ms. Yanqing Liu. The Company is a trading company focusing on the sales of healthcare products and optical glasses.

 

2.PRINCIPAL ACCOUNTING POLICIES

 

2.1Basis of presentation

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

The summary of significant accounting policies presented below is designed to assist in understanding the Company’s financial statements. Such financial statements and accompanying notes are the representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America (“GAAP”) in all material respects and have been consistently applied in preparing the accompanying financial statements.

 

2.2Use of estimates

 

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts reported in the accompanying financial statements and related disclosures. The estimate is based on management’s best knowledge of current events and actions that the Company may take in the future, actual results could materially differ from the estimate.

 

2.3Foreign currency translations

 

The Company’s reporting currency is the United States dollar (“US$” or “U.S. dollars”). The Company’s functional currency is the Renminbi (“RMB”).

 

Transactions denominated in currencies other than functional currencies are translated at the exchange rates quoted by the People’s Bank of China (the “PBOC”), prevailing or averaged at the dates of the transaction for PRC. Gains and losses resulting from foreign currency transactions are included in the statements of income and comprehensive loss. Monetary assets and liabilities denominated in foreign currencies are translated using the applicable exchange rates quoted by the PBOC at the balance sheet dates. All such exchange gains and losses are included in the statement of income.

 

Assets and liabilities of the Company are translated at the current exchange rates quoted by the PBOC in effect at the balance sheet date, equity accounts are translated at historical exchange rates and revenues and expenses are translated at the average exchange rate in effect during the reporting period to US$. Gains and losses resulting from foreign currency translation to reporting currency are recorded in accumulated other comprehensive loss in the statements of changes in Shareholders’ equity for the year presented.

 

The following table outlines the currency exchange rates that were used in creating the consolidated financial statements in this report: 

 

  December 31,
2021
  December 31,
2020
Year-end spot rate US$1= 6.3757 RMB   US$1= 6.5249 RMB
Average rate for the year US$1= 6.4474 RMB   US$1= 6.8941 RMB

 

7

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

NOTES TO THE FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

2.4Cash and cash equivalents

 

Cash and cash equivalents consists of petty cash on hand and cash held in banks, which are highly liquid and are unrestricted as to withdrawal or use. The Company maintains all bank accounts in the mainland China. Cash balances in bank accounts in mainland China are not insured by the Federal Deposit Insurance Corporation or other programs.

 

2.5Accounts receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company reviews on a periodic basis for doubtful accounts for the outstanding trade receivable balances based on historical experience and information available. Additionally, the Company makes specific bad debt provisions based on (i) specific assessment of the collectability of all significant accounts; and (ii) any specific knowledge which the Company has acquired that might indicate that an account is uncollectible. The facts and circumstances of each account may require the Company to use substantial judgment in assessing its collectability. As of December 31, 2021 and 2020, no allowance has been made for accounts receivables.

 

2.6Inventories

 

Inventories are stated at the lower of cost and net realizable value. Cost elements of inventories comprise the purchase price of products, shipping charges to receive products from the suppliers when they are embedded in the purchase price. Cost is determined using the weighted average method. Provisions are made for excessive, slow moving, expired and obsolete inventories as well as for inventories with carrying values in excess of market. Certain factors could impact the realizable value of inventory, so the Company continually evaluates the recoverability based on assumptions about customer demand and market conditions. The evaluation may take into consideration historical usage, inventory aging, expiration date, expected demand, anticipated sales price, product obsolescence and other factors. The reserve or write-down is equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory reserves or write-downs may be required that could negatively impact the Company’s gross margin and operating results. If actual market conditions are more favorable, the Company may have higher gross margin when products that have been previously reserved or written down are eventually sold. As of December 31, 2021 and 2020, management compared the cost of inventories with their net realizable value and determined no inventory write-down was necessary.

 

2.7Property, plant and equipment, net

 

Property, plant and equipment is stated at cost less accumulated depreciation. Maintenance and repairs are charged to expense as incurred. Depreciation is provided on the straight-line method based on the estimated useful lives of the assets as follows:

 

  Useful Lives
Office Equipment 5 Years

 

Expenditures for maintenance and repairs, which do not materially extend the useful lives of the assets, are charged to expense as incurred. Expenditures for major renewals and betterment which substantially extend the useful life of assets are capitalized. The cost and related accumulated depreciation of assets retired or sold are removed from the respective accounts, and any gain or loss is recognized in the consolidated statements of income and other comprehensive income in other income or expenses.

 

2.8Impairment of Long-Lived Assets

 

Long-lived assets are reviewed for impairment when events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. Long-lived assets with carrying values that are not expected to be recovered through future cash flows are written down to their estimated fair values. The carrying value of a long-lived asset is deemed not recoverable if it exceeds the sum of undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the asset’s carrying value exceeds the sum of its undiscounted cash flows, a non-cash asset impairment charges equal to the excess of the asset’s carrying value over its estimated fair value is recorded. Fair value is defined as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at a specified measurement date. We measure fair value using market price indicators or, in the absence of such data, appropriate valuation technique.

 

8

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

NOTES TO THE FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

2.9Revenue recognition

 

The Company adopted ASC Topic 606, Revenue from Contracts with Customers, effective as of January 1, 2019. Accordingly, the financial statements for the years ended December 31, 2021 and 2020 are presented under ASC 606. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is the transaction price the Company expects to be entitled to in exchange for the promised services in a contract in the ordinary course of the Company’s activities and is recorded net of value-added tax (“VAT”). To achieve that core principle, the Company applies the following steps:

 

Step 1: Identify the contract (s) with a customer

Step 2: Identify the performance obligations in the contract

Step 3: Determine the transaction price

Step 4: Allocate the transaction price to the performance obligations in the contract

Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation

 

The Company generates revenues from sales of healthcare products and optical glasses. No practical expedients were used when adoption ASC 606. Revenue recognition policies for the revenue is as follow:

 

Sales of goods

 

The Company sells healthcare products, optical glasses and etc. The performance obligation is completed when the goods are transferred to the customers. The transaction price is determined according to the contract as well as the sales order. Generally, the credit term is within three months. There is no other obligation in the contracts, such as return, refund or warranties. Revenue is recognized at the point in time when the goods are transferred to the customers.

 

Principal and Agent Considerations

 

GAAP requires us to evaluate, using a control model, whether the Company itself promises to provide services to the customers (as a principal) or to arrange for services to be provided by another party (as an agent). In determining whether the Company acts as the principal or an agent, the Company follows the accounting guidance for principal-agent considerations. The determination of whether the Company is acting as a principal or an agent in a transaction involves judgment and is based on an evaluation of the terms of each arrangement. While none of the factors identified in this guidance is individually considered presumptive or determinative, the Company concluded that, during the years ended December 31, 2021 and 2020, gross revenue treatment appropriate for the sales of goods revenue stream.

 

2.10Cost of revenues

 

Cost of revenues consists primarily of the cost of goods sold.

 

2.11General and administrative expenses

 

General and administrative expenses consist primarily of payroll and related compensation for employees engaged in management and administration incurred by those employees and other general corporate expenses.

 

2.12Taxation

 

Current income taxes are provided for in accordance with the relevant statutory tax laws and regulations.

 

Income taxes are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and for operating loss and tax credit carry-forwards. Deferred income taxes are measured using the currently enacted tax rate and laws. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statement of operations in the period that includes the enactment date change. A valuation allowance is provided to reduce the carrying amount of deferred tax assets if it is considered more likely than not that some portion, or all, of the deferred tax assets will not be realized.

 

9

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

NOTES TO THE FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

The Company recognizes a tax benefit associated with an uncertain tax position when, in management’s judgment, it is more likely than not that the position will be sustained upon examination by a taxing authority. For a tax position that meets the more-likely-than-not recognition threshold, the Company initially and subsequently measures the tax benefit as the largest amount that the Company judges to have a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority. The liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances, such as the progress of tax audits, case law developments and new or emerging legislation. Such adjustments are recognized entirely in the period in which they are identified. The effective tax rate for the Company includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. The Company classifies applicable interest and penalties recognized on the liability for unrecognized tax benefits as income tax expense. The Company did not record any unrecognized tax benefits during the years ended December 31, 2021 and 2020.

 

Value-added Tax (“VAT”)

 

Value-added taxes (“VAT”) collected from customers relating to product sales and remitted to governmental authorities are presented on a net basis. VAT collected from customers is excluded from revenue. The Company is generally subject to the value added tax (“VAT”) for selling product and providing advertising services. The Company is subject to a VAT rate of 13% for selling products.

 

2.13Comprehensive income (loss)

 

Comprehensive income consists of two components, net income and other comprehensive income. Other comprehensive income refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of equity but are excluded from net income. Other comprehensive income consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

 

2.14Recently accounting pronouncements

 

In June 2016, the FASB amended guidance related to the impairment of financial instruments as part of ASU2016-13 Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which will be effective January 1, 2020. The guidance replaces the incurred loss impairment methodology with an expected credit loss model for which a company recognizes an allowance based on the estimate of expected credit loss. In November 2018, the FASB issued ASU No. 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, which clarified that receivables from operating leases are not within the scope of Topic 326 and instead, impairment of receivables arising from operating leases should be accounted for in accordance with Topic 842. On May 15, 2019, the FASB issued ASU 2019-05, which provides transition relief for entities adopting the Board’s credit losses standard, ASU 2016-13. Specifically, ASU 2019-05 amends ASU 2016-13 to allow companies to irrevocably elect, upon adoption of ASU 2016-13, the fair value option for financial instruments that (1) were previously recorded at amortized cost and (2) are within the scope of the credit losses guidance in ASC 326-20, (3) are eligible for the fair value option under ASC 825-10, and (4) are not held-to-maturity debt securities. For entities that have adopted ASU 2016-13, the amendments in ASU 2019-05 are effective for fiscal years beginning after December 15, 2019, including interim periods therein. An entity may early adopt the ASU in any interim period after its issuance if the entity has adopted ASU 2016-13. For all other entities, the effective date will be the same as the effective date of ASU 2016-13. In November 2019, the FASB issued ASU 2019-11, “Codification Improvements to Topic 326, Financial Instruments – Credit Losses.” ASU 2019-11 is an accounting pronouncement that amends ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” The ASU 2019-11 amendment provides clarity and improves the codification to ASU 2016-03. The pronouncement would be effective concurrently with the adoption of ASU 2016-03. The pronouncement is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. In February 2020, the FASB issued ASU No. 2020-02, which provides clarifying guidance and minor updates to ASU No. 2016-13 – Financial Instruments – Credit Loss (Topic 326) (“ASU 2016-13”) and related to ASU No. 2016-02 - Leases (Topic 842). ASU 2020-02 amends the effective date of ASU 2016-13, such that ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact this ASU will have on its financial statements and related disclosures.

 

10

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

NOTES TO THE FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Updates (“ASUs”) ASU 2016-02, “Leases (Topic 842),” which increases lease transparency and comparability among organizations. The new guidance, which creates new accounting and reporting guidelines for leasing arrangements, requires organizations that lease assets to recognize assets and liabilities on the balance sheet related to the rights and obligations created by those leases, regardless of whether they are classified as finance or operating leases. Consistent with current guidance, the recognition, measurement, and presentation of expenses and cash flows arising from a lease primarily will depend on its classification as a finance or operating lease. The guidance also requires new disclosures to help financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The new standard is effective for public business entities for annual reporting periods beginning after December 15, 2018, including interim periods within that reporting period, with early application permitted. In March 2019, the FASB issued ASU 2019-01, Leases (Topic 842) Codification Improvements, which further clarifies the determination of fair value of the underlying asset by lessors that are not manufacturers or dealers and modifies transition disclosure requirements for changes in accounting principles and other technical updates. The amendments in ASU 2019-01 amend Topic 842 and the effective date of those amendments is for fiscal years beginning December 15, 2019, and interim periods within those fiscal years for public business entities. For all other entities, ASC 842 is effective for annual periods beginning after December 15, 2021. The Company is currently evaluating the impact of the new pronouncement on its consolidated financial statements but does not expect it to have a significant impact.

 

Except for the above-mentioned pronouncements, there are no new recent issued accounting standards that will have a material impact on the financial position, statements of operations and cash flows.

 

3.ACCOUNTS RECEIVABLE

 

The following table summarized the details of the Company’s accounts receivables and allowance for doubtful accounts:

 

   2021   2020 
         
Account receivable  $680,929   $2,341,933 
Less: allowance for doubtful accounts          
   $680,929   $2,341,933 

 

4.PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

As of December 31, 2021 and 2020, all the balance of prepaid expenses and other current assets are the VAT to be deducted, prepaid cost of goods and deposits.

 

5.Property, plant and equipment, net

 

   2021   2020 
         
Office equipment  $2,403   $2,348 
Less: accumulated depreciation   (2,095)   (1,410)
   $308   $938 

 

As of December 31, 2021 and 2020, there were not any pledged assets.

 

For the years ended December 31, 2021 and 2020, depreciation expenses were $685 and $555, respectively.

 

11

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

NOTES TO THE FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

6.OTHER PAYABLES AND ACCRUED LIABILITIES

 

   2021   2020 
         
Salary payables  $1,333   $4,732 
Accrued expenses and other current liabilities   13,453    7,391 
   $14,786   $12,123 

 

7.TAXES

 

The Company generated substantially all of its income/ (loss) from its PRC operations for the years ended December 31, 2021 and 2020.

 

Income Tax

 

On March 16, 2007, the National People’s Congress of PRC enacted an Enterprise Income Tax Law (“EIT Law”), under which Foreign Investment Enterprises (“FIEs”) and domestic companies would be subject to enterprise income tax (“EIT”) at a uniform rate of 25%. The EIT Law became effective on January 1, 2008. 25% tax rates apply to all the PRC operation subsidiaries in the Company.

 

The provision for income tax for the years ended December 31, 2021 and 2020, consisted of the following:

 

   2021   2020 
         
Current income tax provision  $266,277   $193,413 
Total  $266,277   $193,413 

 

Uncertain tax positions

 

The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of December 31, 2021 and 2020, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur any interest and penalties related to potential underpaid income tax expenses for the years ended December 31, 2021 and 2020, respectively, and also did not anticipate any significant increases or decreases in unrecognized tax benefits in the next 12 months from December 31, 2021.

 

8.SHAREHOLDERS’ EQUITY

 

Paid-in capital

 

The paid-in capital is as follows:

 

   2021   2020 
         
Individual shareholders   69,320    69,320 
Total  $69,320   $69,320 

 

Statutory Reserve

 

The Company is required to make appropriations to certain reserve funds, comprising the statutory surplus reserve and the discretionary surplus reserve, based on after-tax net income determined in accordance with generally accepted accounting principles of the PRC (“PRC GAAP”). Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entity’s registered capital. Appropriations to the discretionary surplus reserve are made at the discretion of the Board of Directors. The reserved amounts as determined pursuant to PRC statutory laws totaled $143,229 and $61,223 as of December 31, 2021 and 2020, respectively.

 

12

 

 

FUZHOU HEKANGYUAN TRADING CO., LTD.

 

NOTES TO THE FINANCIAL STATEMENTS

AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

9.COMMITMENTS AND CONTINGENCIES

 

As at December 31, 2021, the Company had no commitment and contingency that needed to be disclosed.

 

10.CONCENTRATION OF CUSTOMERS AND SUPPLIERS

 

All revenue were derived from customers located in PRC. For the year ended December 31, 2021, the sales to the three largest customers, Happy Buy (Fujian) Network Technology Co., Ltd., Xinbamin Food Distribution (Fujian) Co., Ltd and Wuhan Suochuang Industrial Co., Ltd., accounted for approximately 27.8%, 24.4% and 20.2% of total revenues of the Company, respectively. For the year ended December 31, 2020, the sales to the four largest customers, Xinbamin Food Distribution (Fujian) Co., Ltd., Xiamen Wobisen trading Co., Ltd., Heyuan Tianhui Optical Co., Ltd., Gonghao Industrial Co., Ltd. and Happy Buy (Fujian) Network Technology Co., Ltd. contributed approximately 14.6%, 12.3%, 12.1%, 12.0% and 11.4% of total revenues of the Company, respectively.

 

For the year ended December 31, 2021, the four largest suppliers, Pujing Optical (Guangxi) Co., Ltd., Xiamen Xiaoyaoyao Pharmaceutical Technology Co., Ltd., Huasheng Agricultural Development (Fujian) Co., Ltd. and Hangzhou Xiaoyaoyao Pharmaceutical Technology Co., Ltd., accounted for approximately 34.0%, 19.6%, 15.5% and 14.5% of total purchases of the Company, respectively. For the year ended December 31, 2020, the three largest suppliers, Pujing Optical (Guangxi) Co., Ltd., Zhongfu Daming Group Co., Ltd. and Huasheng Agricultural Development (Fujian) Co., Ltd., accounted for approximately 47.9%, 15.9% and 12.5% of total purchases of the Company, respectively.

 

11.SUBSEQUENT EVENTS

 

In preparing these financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through February 14, 2022, the date the financial statements were available to be issued. No other events require adjustment to or disclosure in the financial statements.

 

 

13

 

 

Exhibit 99.2

 

UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION

 

On February 21, 2022, Happiness Development Group Limited, (“Happiness”), a holding company incorporated under the laws of the Cayman Islands entered into a Securities Purchase Agreement (the “SPA”) with Mrs. Lin Cunhun and Mrs. Liu Yanqing, the shareholders of Fuzhou Hekangyuan Trading Co., Ltd. (“Hekangyuan”), to acquire 100% equity of Hekangyuan with $8 million in cash and 10 million restricted shares of the Company.

 

The following unaudited pro forma combined financial statements were prepared by applying certain pro forma adjustments to the historical financial statements of the Company. The pro forma adjustments give effect to the transaction described above.

 

The unaudited pro forma combined statements of operations of Happiness and Hekangyuan for the six months ended September 30, 2021 and for the year ended March 31, 2021, give effect to the transaction as if it had occurred on April 1, 2020.

 

These unaudited pro forma consolidated financial statements do not purport to represent what our results of operations or financial condition would have been had the transaction actually occurred on the assumed dates, nor do they purport to project our results of operations or financial condition for any future period or future date. You should read these unaudited pro forma combined financial statements in conjunction with the historical financial statements, including the related notes.

 

 

 

 

PRO FORMA COMBINED BALANCE SHEET

 

AS OF SEPTEMBER 30, 2021

 

(UNAUDITED)

 

  

(A)

Happiness

  

(B)

Hekangyuan

   Pro Forma
Adjustments
    Pro Forma
Balance Sheet
 
ASSETS                 
Current assets                 
Cash and cash equivalents  $45,710,044   $139   $(8,000,000)(1)   $37,710,183 
Accounts receivable   19,195,282    680,929    -     19,876,211 
Inventories   2,428,641    1,452,354    -     3,880,995 
Due from related parties   124,156    -    -     - 
Prepaid expenses and other current assets   19,368,295    5,702    -     19,373,997 
Total current assets   86,826,418    2,139,124    (8,000,000)    80,965,542 
Goodwill   552,567    -    7,214,507(2)    7,767,074 
Property, plant and equipment, net   10,381,490    308    -     10,381,798 
Intangible, net   2,069,316    -    3,268,881(3)    5,338,197 
Other assets   4,315,953    -    -     4,315,953 
TOTAL ASSETS  $104,145,744   $2,139,432   $2,483,388    $108,768,564 
                      
LIABILITIES AND SHAREHOLDERS’ EQUITY                     
Current liabilities                     
Accounts payable  $8,769,624   $608,034   $-    $9,377,658 
Other payables and accrued liabilities   2,083,303    14,786    -     2,098,089 
Income tax payable   509    -    -     509 
Short-term bank borrowings   2,004,502    -    -     2,004,502 
TOTAL LIABILITIES   12,857,938    622,820    -     13,480,758 
                      
SHAREHOLDERS’ EQUITY                     
Ordinary shares   15,977    69,320    (64,320)(4)(5)    20,977 
Additional paid-in capital   29,054,060    -    3,995,000(4)(5)    33,049,060 
Statutory surplus reserve   7,622,765    143,229    (143,229)(5)    7,622,765 
Retained earnings   51,421,031    1,245,216    (1,245,216)(5)    51,421,031 
Accumulated other comprehensive income   3,217,398    58,847    (58,847)(5)    3,217,398)
Total   91,331,231    1,516,612    2,483,388     95,331,231 
Non-controlling interest   (43,425)   -    -     (43,425)
Total shareholders’ equity   91,287,806    1,516,612    2,483,388     95,287,806 
                      
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $104,145,744   $2,139,432   $2,483,388    $108,768,564 

 

2

 

 

Pro Forma Adjustments to the Unaudited Combined Balance Sheet

 

(A)Derived from the unaudited consolidated balance sheet of Happiness as of September 30, 2021.

 

(B)Derived from the audited balance sheet of Hekangyuan as of December 31, 2021 as its yearend is less than 93 days from Happiness’s yearend.

 

(1)Decrease in cash is related to the payment to be made to the sellers.

 

(2)Reflects the goodwill generated from the transaction.

 

(3)Reflects the acquired identified intangible assets from the transaction.

 

(4)Reflects the issuance of 10,000,000 Happiness Shares to the sellers, valued at approximately $4.0 million (or approximately $0.4 per share), which is part of the consideration.

 

(5)Reflects the elimination of the historical statutory surplus reserve, retained earnings and accumulated other comprehensive income of Hekangyuan.

 

3

 

 

 PRO FORMA COMBINED STATEMENT OF OPERATIONS

 

SIX MONTHS ENDED SEPTEMBER 30, 2021

 

(UNAUDITED)

 

  

(A)

Happiness

  

(B)

Hekangyuan

   Pro Forma
Adjustments
   Pro Forma
Statement of
Operations
 
                 
                 
Revenues  $46,884,584   $11,442,263   $      -   $58,326,847 
Cost of revenues   (41,210,047)   (10,428,838)   -    (51,638,885)
Gross profit   5,674,537    1,013,425    -    6,687,962 
                     
Operating expenses:                    
Selling and marketing   11,636,367    -    -    11,636,367 
General and administrative   3,780,718    47,512    -    3,828,230 
Research and development   789,482    -    -    789,482 
Total operating expenses   16,206,567    47,512    -    16,254,079 
                     
Operating Income   (10,532,030)        -    (9,566,117)
                     
Other income (expenses):                    
Interest income   62,737    608    -    63,345 
Interest expense   (38,511)   -    -    (38,511)
Other income, net   114,059    (175)        113,884 
Total other income (expenses), net   138,285    433    -    138,718 
                     
Income before income taxes   (10,393,745)   966,346    -    (9,427,399)
                     
Income tax provision   (149,429)   (241,587)   -    (391,016)
                     
Net income   (10,543,174)   724,759    -    (9,818,415)
Less: Non-controlling interests   488,314    -    -    488,314 
Comprehensive income attribute to the Company   (10,054,860)   724,759    -    (9,330,101)
                     
Other comprehensive income (loss):                    
Foreign currency translation adjustments   1,607,416    5,394    -    1,612,810 
Comprehensive (loss) /income   (8,935,758)   730,153    -    (8,205,605)
Less: comprehensive income /(loss) attributable to non-controlling interests:   2,523,603    -    -    2,523,603 
Comprehensive (loss) /income attributable to the Company  $(6,412,155)  $730,153   $-   $(5,682,002)
                     
Basic and diluted earnings per ordinary share                    
Basic and diluted   (0.37)   -    -    (0.35)
Weighted average number of ordinary shares outstanding                    
Basic and diluted   26,842,761    -    -    26,842,761 

 

4

 

 

Pro Forma Adjustments to the Unaudited Combined Statement of Operations

 

(A)Derived from the unaudited consolidated statement of operations and comprehensive income of Happiness for the six months ended September 30, 2021.

 

(B)Derived from the unaudited statement of operations and comprehensive income of Hekangyuan for the year ended December 31, 2021, less for the three months ended March 31, 2021 and for the three months ended December 31, 2021.

 

(1)The calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the transaction is being reflected as if it had occurred on April 1, 2021, the calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the shares have been outstanding on April 1, 2021.

 

5

 

 

 PRO FORMA COMBINED STATEMENT OF OPERATIONS

 

YEAR ENDED MARCH 31, 2021

 

(UNAUDITED)

 

  

(A)

Happiness

  

(B)

Hekangyuan

   Pro Forma
Adjustments
   Pro Forma
Statement of
Operations
 
                 
                 
Revenues  $71,484,703   $17,630,349   $       -   $89,115,052 
Cost of revenues   (53,309,102)   (16,479,313)   -    (69,788,415)
Gross profit   18,175,601    1,151,036    -    19,326,637 
                     
Operating expenses:                    
Selling and marketing   9,958,886    1,041    -    9,959,927 
General and administrative   5,030,899    88,293    -    5,119,192 
Research and development   1,660,100    -    -    1,660,100 
Total operating expenses   16,649,885    89,334    -    16,739,219 
                     
Operating Income   1,525,716    1,061,702    -    2,587,418 
                     
Other income (expenses):                    
Interest income   131,901    1,580    -    133,481 
Interest expense   (111,799)   -    -    (111,799)
Other income, net   105,522    (234)        105,288 
Total other income (expenses), net   125,624    1,346    -    126,970 
                     
Income before income taxes   1,651,340    1,063,048    -    2,714,388 
                     
Income tax provision   (959,384)   (266,277)   -    (1,225,661)
                     
Net income   691,956    796,771    -    1,488,727 
Less: Non-controlling interests   94,400    -    -    94,400 
Comprehensive income attribute to the Company   786,356    796,771    -    1,583,127 
                     
Other comprehensive income (loss):                    
Foreign currency translation adjustments   6,113,570    25,215    -    6,138,785 
Comprehensive (loss) /income   6,805,526    821,986    -    7,627,512 
Less: comprehensive income /(loss) attributable to non-controlling interests:   (2,873,378)   -    -    (2,873,378)
Comprehensive (loss) /income attributable to the Company  $3,932,148   $821,986   $-   $4,754,134 
                     
Basic and diluted earnings per ordinary share                    
Basic and diluted   0.03    -    -    0.06 
Weighted average number of ordinary shares outstanding                    
Basic and diluted   26,160,270    -    -    26,160,270 

 

6

 

 

Pro Forma Adjustments to the Unaudited Combined Statement of Operations

 

(A)Derived from the audited consolidated statement of operations and comprehensive income of Happiness for the year ended March 31, 2021.

 

(B)Derived from the audited statement of operations and comprehensive income of Hekangyuan for the year ended December 31, 2021 as its yearend is less than 93 days from Happiness’s yearend.

 

(1)The calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the transaction is being reflected as if it had occurred on April 1, 2021, the calculation of weighted average shares outstanding for basic and diluted net income per share assumes that the shares have been outstanding on April 1, 2021.

 

 

7